about
Genetic research and health disparitiesCurrent perspectives on the immunopathogenesis of systemic sclerosisPleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative DiseasesPharmacology and rationale for imatinib in the treatment of sclerodermaEthnogenetic layering (EL): an alternative to the traditional race model in human variation and health disparity studiesSevere Acro-osteolysis in a Case of Limited Cutaneous Scleroderma.Scleroderma MimickersTherapy for pulmonary arterial hypertension associated with systemic sclerosis.Systemic sclerosis-associated pulmonary arterial hypertensionPulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesMajor histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolCaveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease[The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy].Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings.Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).Lung involvement in systemic sclerosis.An official American Thoracic Society Statement: pulmonary hypertension phenotypesPulmonary arterial hypertension associated with systemic sclerosis.Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials.The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population.Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.Pulmonary arterial hypertension in connective tissue diseases.Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.Autoimmune connective tissue disease: scleroderma.Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.Mast cell regulation of the immune response.Factors associated with gingival inflammation among adults with systemic sclerosis.Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study.Fatigue: an overlooked determinant of physical function in scleroderma.Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility.Short-Term Pulmonary Rehabilitation for a Female Patient with Chronic Scleroderma under a Single-Case Research Design.Therapies for scleroderma-related pulmonary arterial hypertensionFactors associated with oral hygiene practices among adults with systemic sclerosis.Care of patients with scleroderma in the intensive care setting.Stochastic processes in the aetiopathogenesis of scleroderma.The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.
P2860
Q24650579-5EB50868-7524-47EA-8D3C-576D41D477DFQ26741264-E6B5E035-01F8-43BC-962F-B3FA60F5B1D3Q26779081-4506CF4B-3DDC-4C2A-818D-8ECD6892D523Q26825153-41EE1627-9A3A-41DD-8C1D-8A944F201EE7Q29039843-FD35507B-978B-4487-A5C5-9A8FA974B102Q33593532-0B7CA494-C038-4F86-A58C-3BC59BD6C72FQ33625658-42878986-B511-414E-8EBD-C9CA6BADB410Q33805746-FADDB743-D82F-4E1F-B076-67A10B357FA6Q33950086-E83A638F-6DFD-4EDB-89FB-A10220B88D5CQ33956819-31F5B61B-FECB-4718-89C2-DACC4BAC9454Q33965825-4BEB9D11-44A3-440C-A2E0-E4BAD3CB02E5Q34046875-85BF198F-DF48-417F-8A7F-CF9AFE729BC7Q34152046-F9B35CE1-B384-4210-8C63-6603486E70DEQ34154288-BB34597A-4546-4220-949D-27FDA1F562DBQ34250693-288EA8F2-6ECA-46C4-BAD2-38C89425BB85Q34267840-43299AC2-02D8-4780-A9FA-23CF2381149CQ34295337-40B05ABF-DE24-4B3E-8E7B-0BB55DEEBE39Q34504541-91247B8B-C088-4072-AB6E-CC954D081FC4Q34732817-AC0DDC8F-31BC-4E61-9E16-C83AF3FBE787Q34919733-9351271E-8B0B-46BA-9962-A2D44730F763Q35002423-4F2F6D77-292F-4A45-A9D4-CFD2B668ADD5Q35022904-EED14C85-2EC3-48F6-A0D7-E7340D8D7B0FQ35850289-1B7992B0-02BB-481D-BB62-E4951C39FC37Q36001984-FC8901A5-9E79-4FCF-919F-0BE8F3F3D4FCQ36075852-087C2CB8-FCEE-40C7-94C2-DB66F7A4A091Q36153763-C3DA45FC-0386-41EA-875C-849CD7ABC1DCQ36579178-17119EEE-B206-4935-8B9D-307570222D1AQ36608862-BBC4D986-2250-45A4-9BD7-A67907AACFB8Q36773107-C6B39FF6-E2E7-42C6-96D4-64383788B03EQ36834357-EA3CB3F7-EFF6-4484-ABB5-263B042D4A88Q37045999-FB7E9AE0-C3AC-414A-A25D-8E252CD8C95CQ37073828-394CCD98-364C-4232-9690-8D09A01DD217Q37089576-E948D397-B96B-4135-BB52-6F61F2AA7D87Q37241504-31E5D3C9-CBE4-4063-8B53-80438E76F63FQ37312906-FFFA29A0-DF67-48D6-AB75-13A113257887Q37364799-C2B8E146-C114-43F5-8463-C1D47DE495C2Q37705290-A7523D03-6E6A-4377-A9E7-7E212EB71490Q37764618-B7880FD2-8DB0-497F-BA31-0C84544FE883Q37972707-816D887E-3421-45EC-8AC0-DECDE9B9905CQ37973712-FA5E4DFB-DE57-489A-9684-6FB79E76FF16
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Scleroderma epidemiology.
@ast
Scleroderma epidemiology.
@en
Scleroderma epidemiology.
@nl
type
label
Scleroderma epidemiology.
@ast
Scleroderma epidemiology.
@en
Scleroderma epidemiology.
@nl
prefLabel
Scleroderma epidemiology.
@ast
Scleroderma epidemiology.
@en
Scleroderma epidemiology.
@nl
P1476
Scleroderma epidemiology.
@en
P2093
Maureen D Mayes
P304
P356
10.1016/S0889-857X(03)00022-X
P577
2003-05-01T00:00:00Z